勁方醫藥擬斥最多3.5億元回購H股
上市不足不年的勁方醫藥(2595)公布,董事會正式決議行使購回股份授權,擬不定時於公開市場購回H股,最高金額不超過3.5億元,股份購回期限至購回股份授權期限屆滿。
Last Update:
29 6 月, 2026
Please share this article if you like it!
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.